Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models

Angiogenesis is a characteristic feature of tumours and other disorders. The human monoclonal antibody L19- SIP targets the extra domain B of fibronectin, a marker of angiogenesis expressed in a range of tumours. The aim of this study was to investigate whole body distribution, tumour localisation a...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Emir, E, Dearling, J L J, Huhalov, A, Robson, M P, Boxer, G, Neri, D, van Dongen, G A M S, Trachsel, E, Begent, R H J, Pedley, R B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359968/
https://www.ncbi.nlm.nih.gov/pubmed/17519905
http://dx.doi.org/10.1038/sj.bjc.6603806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359968/
https://www.ncbi.nlm.nih.gov/pubmed/17519905
http://dx.doi.org/10.1038/sj.bjc.6603806

Ejemplares similares